Cargando…
Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
Autores principales: | Adham, Sirin A., Szewczuk, Myron R., Mraiche, Fatima, Petricoin, Emanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793895/ https://www.ncbi.nlm.nih.gov/pubmed/36582793 http://dx.doi.org/10.3389/fonc.2022.1100427 |
Ejemplares similares
-
The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010) -
Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response
por: Al-Zeheimi, Noura, et al.
Publicado: (2019) -
Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Kong, Xianshu, et al.
Publicado: (2022) -
Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: da Silva, Jesse Lopes, et al.
Publicado: (2021) -
Acute Inflammatory Response During Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Case Report
por: Feng, Xiaolan, et al.
Publicado: (2017)